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 Abstract  
Objectives 
Cardiac I-123-MIBG imaging is an established technique for the diagnosis of dementia with Lewy 
bodies (DLB) but various analysis methods are reported in the literature. We assessed different 
methods in the same cohort of subjects to inform best practice. 
Methods 
Seventeen subjects with DLB, 15 with Alzheimer’s disease (AD) and 16 controls were included.  
Planar images were acquired 20 minutes and four hours after injection.  Nine operators 
produced heart-to-mediastinum ratios (HMRs) using freehand and 6, 7 and 8cm diameter 
circular cardiac regions.  Inter-operator variation was measured using the coefficient of variation.  
HMR differences between methods were assessed using ANOVA.  Seven raters assessed the 
images visually.  Accuracy was compared using ROC analysis.  
Results 
There were significant differences in HMR between region methods (p=0.006).  However, with 
optimised cut-offs there was no significant difference in accuracy (p=0.2-1.0).  The sensitivity 
was 65% to 71% and specificity 100% for all HMR methods.  Variation was lower with fixed 
regions than freehand (p<0.001).   Visual rating sensitivity and specificity were 65% and 77% on 
early images and 76% and 71% on delayed images. There was no significant difference in HMR 
between early and delayed images (p=0.4-0.7) although a greater separation between means 
was seen on delayed images (0.73 vs 0.95). 
Conclusions 
HMR analysis using a suitable cut-off is more accurate than visual rating.  Accuracy is similar for 
all methods, but freehand regions are more variable and 6 cm circles easiest to place. We 
recommend calculating HMR using a 6cm circular cardiac ROI on delayed images. 
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 Introduction 
Dementia with Lewy bodies (DLB) is the second most common form of neurodegenerative 
dementia after Alzheimer’s disease, accounting for 5-10% of cases [1, 2].  Accurate diagnosis is 
important for clinical management, prognosis, and carer wellbeing [3-5], but initial misdiagnosis 
outside the specialist setting is common [2, 6, 7].   
Cardiac MIBG sympathetic innervation imaging is an established technique for the differential 
diagnosis of DLB from other dementias, which do not cause sympathetic denervation and thus 
have normal scan appearances.   The technique has been used in Japan for the diagnosis of Lewy 
body disease for over a decade was recently included as an indicative biomarker in the fourth 
DLB consensus criteria, alongside 123I-FP-CIT SPECT [6].  FP-CIT is more widely used than MIBG in 
clinical settings in Europe and is supported by a more substantial evidence base that has been 
validated against autopsy data [8-10]. However a reported sensitivity of 77% suggests many 
patients with DLB have normal FP-CIT findings [11].   
Single centre studies of DLB diagnosis using cardiac MIBG scintigraphy reported sensitivity and 
specificity values of over 90% [12-16].  However, the largest multicentre trial of cardiac MIBG 
scintigraphy in DLB to date (133 DLB and non-DLB dementia patients scanned in Japanese 
centres) reported a sensitivity and specificity of 69% and 89% respectively [17].  This used ROC 
analysis to give optimal separation between the groups, rather than using an independent 
normal cardiac uptake threshold.  With diagnostic revisions after three year follow up of 65 of 
the subjects, these results have been updated to 77% and 97% [18], although the optimal cardiac 
uptake cut-off between DLB and non-DLB was updated based on re-analysis of this subgroup.   
Several authors have commented on the need to standardise cardiac MIBG image acquisition 
and processing parameters in order for cardiac uptake thresholds to be applicable between 
centres, e.g. [19-24].  A method to correct for differences in image acquisition parameters 
between centres (predominantly caused by different gamma camera and collimator models) has 
been developed by Nakajima et al. [25] was used in the multicentre study mentioned above [17, 
18].  However centres outside Japan still tend to publish results generated using local acquisition 
parameters and local normal uptake thresholds [26, 27], omitting information known to affect 
apparent cardiac uptake such as gamma camera model and collimator type, which limits the 
generalisability of the results.  In addition, there is currently no generally accepted method for 
processing and interpreting the images.  Okuda et al. have developed a semi-automated image 
analysis method [28], used in the multicentre study [17], but outside Japan there remains a 
variety of methods in use for interpreting planar cardiac MIBG images for Lewy body disease, 
including visual analysis and semi-quantification.  These issues are discussed in a review article 
by Chen et. al., where it is noted that further studies comparing the accuracy and repeatability 
of different analysis methods are required [29].  To our knowledge only two studies utilising 
visual assessment of cardiac MIBG images in Lewy body disease have been published [27, 30], 
neither directly comparing the accuracy of visual and semi-quantitative methods using statistical 
analysis, and thus there is a need for further work to clarify how the performance of visual rating 
compares with semi-quantitative analysis.   
The majority of studies using cardiac MIBG for the assessment of Lewy body disease acquire 
both early images (acquired 15-20 minutes after MIBG administration) and delayed images (3-4 
hours after administration).  The HMR is usually calculated on the delayed images since these 
are thought to reflect the function of the cardiac sympathetic nerves and early images the 
distribution of the nerves [31].  However, three recent studies carried out in Japan by separate 
groups [30, 32, 33]  demonstrated no significant difference between diagnostic accuracy of early 
 
or delayed imaging for the diagnosis of Lewy body disease, suggesting that early images alone 
may be sufficient.  Acquiring early images alone would benefit both patients and clinical 
departments and would also make the test much more convenient to perform than FP-CIT, 
which requires a 3-6 hour uptake period before scanning. 
In this project we compare planar cardiac MIBG analysis methods for discriminating between 
DLB and Alzheimer’s disease (AD) using dementia and healthy control subjects recruited and 
scanned locally as part of a research study. We compare visual assessment for both early and 
delayed imaging with various semi-quantitative analysis methods, including one as close as 
possible to that used by Nakajima et al. [25], made possible by participating in a European 
multicentre phantom calibration exercise [22].  The overall aim is to determine the optimal 
method for processing and interpreting planar cardiac MIBG images for DLB diagnosis, and the 
best time point for imaging.  This is achieved by considering the variation between operators 
and raters for each method as well as the accuracies given by ROC analysis.   
Methods 
Subjects 
Dementia subjects were recruited as part of the Newcastle University study into the use of 
cardiac MIBG in a representative UK population [34].  Thirty-two of the 33 patients included in 
our previous publication were included in this analysis: 15 with probable AD and 17 with 
probable DLB (one AD subject was excluded here because the early image was not available). 
Diagnoses were made by an expert panel of three old-age psychiatrists (AT, JK, JOB) blinded to 
scan results, based on clinical assessment and applying standard research criteria [6]. This 
consensus panel method has previously been validated against autopsy and is accepted by 
regulatory authorities as the clinical gold standard for living patients [11, 35]. Sixteen healthy 
controls were taken from a separate study recruiting healthy older people.  They had undergone 
the same detailed neurological examination by a research physician as the dementia subjects, 
including rating for parkinsonism with UPDRS, a thorough neurocognitive examination which 
confirmed they had normal cognition and normal MRI brain scan.   
Image acquisition 
Subjects were administered 111 MBq I-123-MIBG via slow intravenous injection.  Potassium 
iodate tablets (170mg) were given before and after injection for thyroid blockade.  Ten minute 
anterior planar images were acquired at 20 minutes (“early”) and 4 hours (± 30 minutes, 
“delayed”).  Images were acquired on a Siemens Symbia T series or Siemens Symbia Intevo 
gamma camera with medium energy low penetration (MELP) collimators and processed on a 
Hermes workstation.  Medium energy collimators are recommended for cardiac MIBG imaging 
by the EANM task group on standardisation [36] since they minimise septal penetration of the 
high energy photons that reduce image contrast.  The energy window was 159 keV ± 10%, matrix 
size was 128 x 128 and no zoom was applied.  The same settings were applied when participating 
in the European phantom calibration study [22].  We used the phantom calibration results for 
our centre to apply a correction factor to the HMR cut-off for DLB diagnosis determined by 
Yoshita et al. [17]. This small correction increases the cut-off for both gamma cameras from 2.10 
to 2.25. 
Visual rating 
Images were anonymised and rated blind to diagnosis on a 4 point scale: definitely abnormal, 
probably abnormal, probably normal or definitely normal.  Seven individuals experienced in 
nuclear medicine reporting (two consultant radiologists and five nuclear medicine physicists) 
 
were recruited as raters.  The raters were provided with a set of reference images for each 
category, including example images for both early and delayed imaging. The modal (most 
frequent) rating was taken as the consensus result.  The results were dichotomised into normal 
or abnormal ratings for the accuracy study and comparison with HMR.  
Heart-to-mediastinum ratio processing 
Nine operators experienced in processing nuclear medicine studies took part in this part of the 
study (six nuclear medicine physicists and three nuclear medicine technologists).  Five of the 
physicists also rated the images visually (see above).  This was carried out in a randomised order 
and before the quantitative results were generated to avoid bias.  Operators were provided with 
comprehensive instructions including example images showing region placement.   
Both the early and delayed anterior images were processed.  We used four different cardiac 
region placement methods: freehand regions delineated manually around the myocardium and 
fixed circular regions of 6, 7 and 8 cm in diameter placed over the centre of the visible 
myocardium.  Smaller regions were not tested because the ventricular cavity apparent on some 
images would lead to an under sampling of counts.  A fixed sized rectangular mediastinum region 
of 4 cm x 3 cm was placed between the apices of the lungs, in an area containing only 
background counts.  The mediastinum region size was chosen to be consistent in shape and 
position within the mediastinum with Okuda et al. [37] but simplified by using a fixed sized 
region placed manually.  The size is small enough not to be subject to interference from the 
lungs and large enough to give a reasonable sample of background counts.   Since there is little 
variability uptake throughout the mediastinum we did not investigate mediastinum region size 
or placement, or automate placement.  The same mediastinum region was used with all four 
cardiac ROIs for HMR calculation.  The heart and mediastinum values were exported and all HMR 
values were calculated by the author using a macro to minimise typographical errors.  An 
example image with manual and circular cardiac ROIs and resulting HMR values is shown in 
Figure 1 
 
Fig 1: Example normal uptake cardiac MIBG image with HMR values for freehand, 6 cm and 8 cm circular cardiac 
regions. 
Analysis 
Difference in HMR between cardiac region methods 
The effect of region drawing method on HMR was tested using a generalised linear model 
ANOVA analysis applying the Greenhouse-Geisser method for conditions where sphericity 
 
cannot be assumed (SPSS Statistics v23.0.0.3 (IBM Corporation)). A p-value of <0.05 was taken 
to indicate a significant dependence of HMR on region method.   
Difference in inter-operator variability between cardiac region methods 
The average coefficient of variation (CoV) was taken as a measure of variability with which to 
compare the region drawing methods. The CoV was calculated for each subject using the result 
for each of the nine operators and these CoV values were averaged to give the mean.  This was 
repeated for each region method and time point.  Paired t-tests were used to test for differences 
in coefficient of variation.   
Difference in accuracy between cardiac region methods 
The HMR value for each subject was taken as the mean of nine operators and these mean values 
used for comparing cardiac region methods.  SigmaPlot v.13 (SystStat Software, San Jose, CA) 
was used to generate ROC curves including all subjects for each method by varying the 
normal/abnormal cut-off, using the consensus diagnoses (with the DLB, AD and control subject 
diagnoses dichotomised as either DLB or non-DLB) as the gold standard.  SigmaPlot output was 
used to check for significant differences between the area under the ROC curves. This allows a 
comparison of overall accuracy of each HMR method to be made.  The best method (time point 
and region combination) was selected based on the area under the curve (accuracy), difference 
between mean DLB and non-DLB HMRs and the average CoV between operators determined 
above. 
The HMR values for the DLB and non-DLB subjects obtained with the method identified as 
optimal were used to determine the sensitivity and specificity for this method.  This was done 
within SigmaPlot by applying the optimal cut-off given by the ROC analysis.    
Difference between early and delayed HMRs  
Paired t-tests were used to test for difference in HMR between early and delayed imaging again 
using a significance level of 0.05 (two-tailed test).  The mean HMR with 95% confidence interval 
was calculated for the DLB and non-DLB groups for each method using SPSS and the mean 
differences calculated.   
Comparison between visual rating and HMR analysis 
The sensitivity and specificity for early and delayed consensus visual ratings were calculated 
from the true and false positive and negative results, using the consensus clinical diagnoses as 
the gold standard.  As above, sensitivity and specificity results were calculated with the DLB, AD 
and control subject diagnoses dichotomised as either DLB or non-DLB. 
To assess agreement between raters, the intraclass correlation coefficient was calculated using 
SPSS for all subjects.  The concordance between early and delayed ratings was calculated as well 
as the number of control images rated as abnormal. 
Results 
Subject characteristics 
The age, sex, MMSE and ACE scores and MDS-UPDRS scores [38] for all subjects are given in 
Table 1.  As expected, there were significantly higher levels of Parkinsonism in the DLB group 
but otherwise the dementia groups were well matched for age and cognition.  The control and 
AD subjects taken as a single non-DLB group were well matched for age and gender mix with the 
DLB group. 
 
Table 1: Clinical characteristics of the AD, DLB and healthy control groups.  In this study we grouped the AD and 
control subjects together to form a single group of “non-DLB” subjects that would be expected to have normal scan 
appearances. 
 Number of 
subjects (no. 
female) 
Mean age 
(min – max) 
Mean MDS-
UPDRS score 
(min – max) 
Mean MMSE 
(min – max) 
Mean ACE 
total (min – 
max) 
Alzheimer’s Disease 15 (4) 76.2 (62 – 85) 5.0 (0 – 27) 22.0 (12 – 26) 64.8 (23 – 85)  
Dementia with Lewy 
bodies 
17 (2) 77.5 (60 – 89) 33.4 (2 – 89) 21.8 (14 – 27) 66.0 (34 – 87) 
Healthy controls 16 (6) 72.3 (61 – 86) 5.4 (0 – 16) 28.6 (26 – 30) 93.6 (85 – 99) 
p-value AD vs DLB  0.31 0.63 <0.001 0.95 0.83 
p-value non-DLB vs 
DLB 
0.09 0.17 <0.001 n/a n/a 
 
 
Effect of cardiac region method on HMR 
The HMR values averaged over the nine operators for each processing method are shown in 
Table 2. The ANOVA repeated measures test demonstrated a significant difference in HMR 
values between the four region drawing methods (F=7.196, p=0.006).  Pairwise comparisons 
showed the largest differences were between the 6cm and freehand regions and the 6 cm and 
8 cm regions.  For fixed circular regions, HMRs tend to decrease with increasing region size, as 
expected (Table 2).    
Table 2: Mean and standard deviation of HMR values over all subjects calculated with freehand and circular cardiac 
regions on early and delayed images.  The p-values test for significant differences between early and delayed HMR 
with each method, using paired t-tests. 
Region method 
Mean early 
HMR (SD) 
Mean delayed 
HMR (SD) 
p 
Freehand 2.22 (0.55) 2.19 (0.66) 0.37 
6cm circle 2.32 (0.60) 2.31 (0.74) 0.70 
7cm circle 2.26 (0.57) 2.25 (0.69) 0.74 
8cm circle 2.19 (0.53) 2.18 (0.64) 0.67 
 
Difference in inter-operator variability between cardiac region methods 
The fixed sized circular methods have a lower average coefficient of variation (CoV), than the 
freehand method (Table 3, p <0.001).  There was no significant difference in variation between 
any two fixed circle HMR methods (p values between 0.14 and 0.84). All methods have a lower 
CoV on delayed images than early images but this was not statistically significant (Table 3).   
 
Table 3: Average coefficients of variation for each region drawing method used for HMR calculation.  All subjects are 
included. 
 
 Region method 
 Freehand 6 cm 7 cm 8 cm 
Early CoV 5.8% 4.9% 4.9% 4.9% 
Delayed CoV  5.7% 4.3% 4.2% 4.2% 
p value (early vs 
delayed) 
0.80 0.37 0.17 0.15 
 
 
Display of ROIs superimposed for all operators showed closer agreement between operators 
with the circular regions than with the freehand region, although this was not analysed using 
statistical testing as region overlap data was not available.  An example image with normal 
uptake and example image with reduced uptake is shown in Error! Reference source not 
found. with freehand regions and 6 cm circular regions for all operators displayed.  Operators 
reported that the 7 and 8 cm circular regions were difficult to place on some images without 
including non-cardiac uptake, for example in the lung or liver. 
 
Fig 2: Top: example normal cardiac MIBG image (top row) and abnormal image (bottom row) processed by multiple 
operators with freehand and 6cm circular regions.  
Difference in sensitivity, specificity and accuracy between cardiac region 
methods 
ROC curves and AUC results for the early and delayed HMR methods are shown in Figure 3, with 
95% confidence intervals given in Table 4.   AUCs were very similar for all methods and there 
were no statistically significant differences in accuracy between any of the region drawing 
methods (p-values ranging between 0.23 and 1.00).   
 
Fig 3: ROC curves for all cardiac region methods on early images (left) and delayed images (right).  
 
The optimal cut-offs for each method were applied to the HMR values for the DLB and non-DLB 
groups.  This gave sensitivities for distinguishing between DLB and non-DLB subjects ranging 
between 65% and 71% for the different region methods.  The specificity with the optimal cut-
offs applied was 100% for all methods.   
The results for the 6cm circle region HMR on delayed imagesError! Reference source not 
found.were 71% sensitivity (95% binomial confidence interval: 44% to 90%) and 100% specificity 
(89% to 100%) using the optimal cut-off of 1.66.  The overall accuracy of this method was 90% 
(77% to 97%). 
Effect of time point on HMR 
Table 5 shows the difference in mean HMR for the DLB and non-DLB groups for each method, 
with 95% confidence intervals around the means.  The difference between group mean HMRs is 
higher for delayed imaging than early imaging for all region sizes, with the delayed 6cm method 
giving the largest difference. 
Table 4: ROC cure areas and 95% confidence intervals for all regions tested. 
 
Table 5: Difference in mean HMR between DLB and non-DLB groups for the HMR methods tested, with 95% 
confidence intervals around the mean HMR values given in brackets 
Time point Region method 
Mean HMR DLB (95% 
CI) 
Mean HMR non-DLB (95% 
CI) Difference 
Early 
Freehand 1.80 (1.49 to 2.12)  2.45 (2.33 to 2.58)  0.65 
 
6cm circle 1.84 (1.51 to 2.19) 2.57 (2.43 to 2.70)   0.73 
 
7cm circle 1.88 (1.51 to 2.25) 2.49 (2.36 to 2.61)  0.61 
 
8cm circle 1.81 (1.50 to 2.12)  2.40 (2.28 to 2.52)  0.59 
Delayed 
Freehand 1.63 (1.28 to 1.98)  2.50 (2.35 to 2.65)  0.87 
 
6cm circle 1.69 (1.28 to 2.10) 2.64 (2.48 to 2.81) 0.95 
 
7cm circle 1.68 (1.30 to 2.06)  2.56 (2.41 to 2.72)  0.88 
 
8cm circle 1.65 (1.31 to 2.00) 2.47 (2.32 to 2.61) 0.82 
 
However, there are no statistically significant differences in HMR between the early and 
delayed images for any region method (p=0.37 to 0.74, Table 2).   The wider range of HMRs on 
delayed imaging (over all subjects) is shown for the 6cm circle region method, which gave the 
largest separation between group means, in Figure 4. 
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 Fig 4: Comparison of early (left) and delayed (right) HMR values for all subjects, showing a wider variation in HMR 
values on the delayed images 
Comparison between visual rating and HMR analysis 
Four of the 32 dementia cases were rated by the panel as normal on early images and abnormal 
on delayed images or vice versa giving a concordance of 88% between early and delayed ratings.  
Concordance between early and delayed image rating was 100% for controls, although two of 
these control cases were rated as abnormal.  Sensitivity was higher for visual rating of delayed 
images than early images but specificity higher for early image rating; the overall accuracy, 
defined as the percentage of correct designations, was the same for both time points (Table 6).   
The agreement between visual raters was very good for both early and delayed images 
(intraclass correlation coefficient of 0.96 (0.94 to 0.98) for both).  Overall, accuracy was lower 
for visual rating (73%) than for HMR analysis (90%), due to the lower specificity. 
Table 6: Sensitivity, specificity and accuracy for distinguishing between DLB and non-DLB subjects using consensus 
visual rating, with binomial confidence intervals in brackets. 
 SENSITIVITY SPECIFICITY ACCURACY 
EARLY VISUAL 65% (38% to 86%) 77% (59% to 90%) 73% (58% to 85%) 
DELAYED VISUAL 76% (50% to 93%) 71% (52% to 86%) 73% (58% to 85%) 
 
The overall concordance between consensus visual rating and mean HMR using the 6cm circle 
method for the controls was 12/16 (75%) for early images and 13/16 (81%) for delayed.  
Overall the concordance between the 6cm circle HMR method and visual rating for delayed 
images for all subjects was 38/48 (79%). 
  
 Discussion 
Effect of cardiac region method on HMR 
We have demonstrated that the region drawing method had a significant impact on HMR values 
and that ROI methods should not be used interchangeably – the appropriate cut-off depends on 
the processing method.  In this dataset, the 6cm circle HMR results were significantly higher 
than the freehand results, likely due to the freehand regions of interest being larger on average 
and so including more non-specific background counts.   
A fixed sized region minimises variation between operators processing the same patient, but 
could in theory lead to inaccuracies for individual patients.  The size of the visible myocardium 
varies between patients, as does the size of the ventricular cavity, often visible on images as a 
“cold” area with low counts.   However our results show very similar accuracy for all methods 
suggesting that this effect is minimal.  Given the higher variation between operators for 
freehand region HMRs and no benefit in accuracy, we recommend that fixed sized circular 
regions be used over freehand. 
The 8cm circle method gave the lowest inter-operator variability.  However, the difference in 
both accuracy and variability between the 8cm and 6cm circle method is very small and not 
statistically significant.  Furthermore, slightly smaller ROIs are less likely to be influenced by non-
cardiac uptake in the liver, lungs or bowel and at the same time less likely to include background 
counts surrounding the LV.  Our study supports the use of the 6cm fixed circle method used in 
several previous publications, and we therefore suggest that this be adopted as standard. 
Accuracy of visual rating compared with HMR analysis 
In our study, consensus visual rating with binary outcome (i.e. probable/definite normal vs 
probable/definite abnormal) performed less well than using an HMR cut-off, with a lower 
specificity for detecting DLB and two of the 16 control subjects rated as probably abnormal.  Of 
the two controls rated as probably abnormal on both early and delayed imaging, one had 
borderline HMR values on delayed imaging using the 6cm circle method (2.16), but not on early 
(2.47).  The other control rated as abnormal had normal HMR values on both early and delayed 
imaging (2.47; 2.57).   
Tiraboschi et al. [27] used binary (normal / abnormal) visual image assessment (consensus of 
three raters) as their primary analysis method in their study comparing cardiac MIBG and FP-CIT 
for DLB diagnosis, with HMR analysis as a secondary method.  In contrast to our study, their 
results show 100% specificity for both visual and HMR techniques (95% confidence interval 88-
100%).  The sensitivity is slightly higher for the HMR method than visual consensus (97% vs 93%) 
but the confidence intervals overlap considerably and the authors state the results were similar 
[27].  We found that extending our normal categorisation to include the “probably abnormal” 
category improved specificity without having a large impact on sensitivity, suggesting that any 
level of cardiac uptake above background is likely normal. However such a system may not be 
useful in detecting early disease, where we might expect to see subtly reduced uptake. 
Although the heart-to-mediastinum ratio is intended to be objective, it may be affected by the 
amount of lung and liver uptake and proximity to the heart.  In publications using HMR results, 
visual inspection of images for confounding factors potentially affecting HMR is not typically 
mentioned.  The presence of lung uptake on MIBG scans is normal and is due to uptake by 
pulmonary endothelial cells [39, 40].  Reduced lung uptake has been reported in Lewy body 
disease [41] and has been linked to treatment with L-dopa leading to an increase in plasma 
homocysteine levels [42].   Reduced lung uptake in DLB due to medication could potentially 
 
exaggerate the difference in HMR between DLB and non-DLB groups, due to reduced scatter 
from the lungs into the cardiac ROI in those taking L-dopa.  However, although ours is a small 
sample, we found no evidence of any correlation between L-dopa dose and lung uptake for DLB 
patients.   
We recommend HMR analysis be used as the primary method of assessment for planar cardiac 
MIBG images for DLB diagnosis, rather than visual rating.  However the visual appearance of the 
study should still be taken into account, particularly in borderline cases where extra-cardiac 
uptake could give confounding results.   
Difference between early and delayed imaging 
Our results show no significant difference between HMR values taken on early and delayed 
images for dementia subjects or healthy controls.  Examining the literature on early versus 
delayed MIBG in dementia and Lewy body disease we found two articles that stated early MIBG 
imaging was more accurate, 13 that stated delayed imaging was more accurate and 18 that 
reported no difference. However, only five of these compared early and delayed statistically, 
four of which showed no significant differences [30, 32, 33, 43].  Yoshita et al. [44] demonstrated 
that HMR values in Parkinson’s disease were significantly lower on delayed images than early 
images, whereas control HMR values were the opposite and were higher on the delayed images.  
The differences between early and late HMR were statistically significant.   
It is possible that there is a true difference in the accuracy of early and delayed imaging but that 
our dataset is too small to reach statistical significance.  Several of our subjects had quite 
different uptake levels on delayed imaging compared to early; this did not affect 
normal/abnormal categorisation with the optimal ROC cut-offs applied, but would have done 
with the higher prior cut-off of 2.25 applied.  Furthermore, we tended to see greater differences 
in mean HMR between our DLB and non-DLB groups on delayed imaging compared with early, 
which is in keeping with previous studies, including those that demonstrated no statistically 
significant difference in diagnostic accuracy between early and delayed imaging [33, 43].  Given 
the uncertainty in the literature, the theoretical advantage of delayed images, which are thought 
to demonstrate function rather than distribution of the cardiac sympathetic nerves, we do not 
recommend using early images alone in research studies.  However, in clinical practice the 
delayed image could be omitted if the early image showed a non-equivocal result, saving time 
in the majority of cases. 
Use of an HMR cut-off from a published multicentre study  
The results of a recent study at our centre [34] suggest that our threshold of 2.25 adapted from 
the Japanese multicentre study [17] is too high, as several patients with clear Alzheimer’s 
disease and without clinical signs suggestive of Lewy body disease have HMR values below this 
cut-off.  Similarly, the lowest control HMR value is 2.16 (6cm circle method on delayed images).  
The optimal cut-off for this dataset calculated using ROC analysis was only 1.66, giving 71% 
sensitivity and 100% specificity.   With the prior cut-off of 2.25 applied the sensitivity would 
remain 71% but specificity drop to 87%, due to three AD subjects and one control subject 
becoming false positives. 
Since calibration actually increased the cut-off obtained in the multicentre study from 2.10 to 
2.25 for our centre, we conclude that the discrepancy in specificity is likely to be due to 
differences in the patient population studied, rather than due to differences between 
acquisition parameters.  Indeed, different optimal HMR cut-offs were found in the three-year 
follow up to the Yoshita study [18], which used 65 of the original 113 subjects.   
 Conclusion 
HMR values depend on the method used to draw the cardiac region, with the smallest region 
(6cm diameter) giving the highest values.  Accuracy is similar for all HMR methods but inter-
operator variation lower for fixed sized ROI methods than freehand.  Visual rating specificity is 
lower than HMR methods so HMR should be used as the primary reporting method, provided 
an appropriate cut-off for the gamma camera(s) used has been established.   We found no 
significant difference in HMR between early and delayed images.  However, the separation 
between the mean HMR of DLB and non-DLB groups did tend to be greater for delayed methods; 
further studies using both early and delayed imaging would be needed to confirm this.      
Given that all fixed sized region HMR methods give similar results, we recommend using a 6cm 
diameter circular region for research studies; this is in keeping with published methods and may 
reduce the effect of non-cardiac uptake compared to larger ROIs.  As there are theoretical 
advantages to delayed imaging, we recommend continuing to acquire delayed images for 
research studies even though the accuracy of early images appears to be similar.   The sensitivity 
and specificity of the 6cm ROI method on delayed images with optimal cut-off of 1.66 were 71% 
and 100%.   
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